ストックスクリーナーアプリを入手
44.05
0.70%
-0.3112
アフターアワーズ：
44.11
0.0598
+0.14%
前日終値:
$44.36
開ける：
$44.36
24時間の取引高:
29,144
Relative Volume:
1.03
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.22%
1か月 パフォーマンス:
+5.79%
6か月 パフォーマンス:
+17.45%
1年 パフォーマンス:
+62.66%
1日の値動き範囲:
$43.92
$44.36
1週間の範囲:
$42.73
$44.79
52週間の値動き範囲:
$26.62
$47.00
Tema Oncology Etf Stock (CANC) Company Profile
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
44.05 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
379.73 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
770.19 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.92 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.01 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
718.96 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf (CANC) 最新ニュース
Discipline and Rules-Based Execution in CANC Response - news.stocktradersdaily.com
EXCLUSIVE: AI, Genomics Could Fuel Biotech ETF Re-Rating as Health Care Trades at Discount, Says Expert - Benzinga
Why Healthcare Is Worth Revisiting as 2026 Draws to a Close - Tema ETFs
Biotech ETF (CANC) Hits New 52-Week High - Yahoo Finance
(CANC) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Anders Storm Appointed Expert Advisor to Tema Photonics & Optical ETF (LAZR) - Business Wire
TEMA ONCOLOGY ETF (CANC) Stock Chart - ChartMill
Price-Driven Insight from (CANC) for Rule-Based Strategy - Stock Traders Daily
ETFs Investing in BridgeBio Oncology Therapeutics, Inc. Stocks - TradingView
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years - The National Law Review
BridgeBio Oncology Therapeutics Ord Shs (BBOT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Memory Giant CXMT Becomes a Top Holding in Tema Memory ETF (DISK) - Business Wire
ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView
CG Oncology Inc (CGON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(CANC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Tema Launches Healthcare AI ETF (HLTH) - Tema ETFs
CANC ETF Profile: Dividends, Returns (BOATS:CANC) - TradingView
CANC ETF Profile: Dividends, Returns (NASDAQ:CANC) - TradingView
CANCTema Oncology ETF Earnings - Finviz
(CANC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Tema ETFs and SemiAnalysis Launch Exclusive Semiconductor ETF Partnership - Tema ETFs
(CANC) Risk Channels and Responsive Allocation - Stock Traders Daily
Ascentage Pharma Group International (AAPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcellx Inc (ACLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Merus NV (MRUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pyxis Oncology Inc (PYXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Helix Acquisition Corp II (HLXB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(CANC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Liquidity Mapping Around (CANC) Price Events - Stock Traders Daily
CANC Stock Price, Quote & Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
Why (CANC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Understanding Momentum Shifts in (CANC) - Stock Traders Daily
Pancreatic Cancer's Turning Point, and the RAS Revolution Ahead - Tema ETFs
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
Tema ETFs Announces Product Updates - Tema ETFs
Tema Electrification ETF (VOLT) Surpasses $500 Million in AUM - Tema ETFs
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks - Seeking Alpha
CANC: First Look At This Addressing Cancer ETF Results In A Hold Rating (Retired Investor) (NASDAQ:CANC) - Seeking Alpha
Behavioral Patterns of CANC and Institutional Flows - Stock Traders Daily
Tema Launches First Pure-Play Space ETF to Offer SpaceX Exposure - Tema ETFs
(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Electrification is an American Story - Tema ETFs
Biotech stocks and longevity investing: Trends to track - North Scott Press
Tema Oncology Etf (CANC) 財務データ
Tema Oncology Etf (CANC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.48%
0.13%
大文字化:
|
ボリューム (24 時間):